Hsbc Holdings PLC Tiziana Life Sciences LTD Call Options Transaction History
Hsbc Holdings PLC
- $159 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding TLSA
# of Institutions
35Shares Held
3.04MCall Options Held
24KPut Options Held
800-
Dauntless Investment Group, LLC Commerce Township, MI1.74MShares$3.1 Million2.2% of portfolio
-
Jane Street Group, LLC New York, NY168KShares$298,2240.0% of portfolio
-
Omers Administration Corp Toronto, A6145KShares$257,9220.0% of portfolio
-
Morgan Stanley New York, NY139KShares$247,4760.0% of portfolio
-
Zhang Financial LLC96.3KShares$171,3420.01% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $182M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...